Collegium Pharmaceutical (COLL) Other financing activities (2018 - 2025)

Collegium Pharmaceutical (COLL) recorded quarterly Other financing activities of $964000.0 in Q3 2025, up 125.23% quarter-over-quarter from $428000.0 in Q2 2025, and up 578.87% on a YoY basis from $142000.0 in Q3 2024.

Collegium Pharmaceutical (COLL) Other financing activities (2018 - 2025) Analysis & Trends

Collegium Pharmaceutical's Other financing activities history runs 3 years deep, the most recent figure standing at $964000.0 for Q3 2025.

  • In Q3 2025, Other financing activities rose 578.87% year-over-year to $964000.0; the TTM figure through Sep 2025 stood at $12.1 million (down 35.81% YoY), while the FY2015 annual figure was -$16000.0, changed N/A from the prior year.
  • Other financing activities was $964000.0 for Q3 2025 at Collegium Pharmaceutical, up from $428000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $12.9 million in Q1 2024 to a low of $142000.0 in Q3 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Collegium Pharmaceutical 1.10 Bn 813.71 Mn 117.25 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 964,000.00
Sep 30, 2025 964,000.00
Jun 30, 2025 428,000.00
Jun 30, 2025 428,000.00
Mar 31, 2025 10.59 Mn
Mar 31, 2025 10.59 Mn
Sep 30, 2024 142,000.00
Sep 30, 2024 142,000.00
Jun 30, 2024 5.88 Mn
Jun 30, 2024 5.88 Mn
Mar 31, 2024 12.87 Mn
Mar 31, 2024 12.87 Mn
Mar 31, 2018 30,000.00
Mar 31, 2018 30,000.00